Mei Mei Hu - 07 Mar 2023 Form 4 Insider Report for Vaxxinity, Inc.

Reporting relationship: Chief Executive Officer and President., Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 07 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Apr 2023, 16:56:40 UTC
Prior SEC filing: 21 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Rene Paula Molina as Attorney-in-Fact for Mei Mei Hu

Key filing fact

Mei Mei Hu filed Form 4 for Vaxxinity, Inc. on 05 Apr 2023.

Key facts

This page summarizes Mei Mei Hu's Form 4 filing for Vaxxinity, Inc..
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Apr 2023, 16:56.

Change

Previous filing in this sequence was filed on 21 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VAXX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +620,000
Change %
Price: $0.000000
Shares after: 620,000
Date: 07 Mar 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 620,000
Exercise price: $2.29
Footnotes: F1

VAXX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +73,928
Change %
Price: $0.000000
Shares after: 73,928
Date: 07 Mar 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 73,928
Exercise price: $2.29
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 48 equal monthly installments beginning on March 7, 2023.

Footnote F2

The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options are fully vested upon issuance. This one-time option grant was made in lieu of an annual cash bonus payment to Ms. Hu.

SEC remarks

Chief Executive Officer and President.